[1] 徐丽,毛居旦·阿不力孜,杨丽.缺血性脑卒中患者血清miR-17-5p、miR-27b-3p水平及其对中重度颅内外动脉狭窄预测价值[J].临床误诊误治,2021,34(7):95-100. [2] GBD 2019 Stroke Collaborators. Global,regional,and national burden of stroke and its risk factors,1990-2019:a systematic analysis for the Global Burden of Disease Study2019[J].Lancet Neurol,2021,20(10):795-820. [3] SIEGLER J E, KLEIN P, YAGHI S, et al.Cerebral vein thrombosis with vaccine-induced immune thromboticthrombocytopenia[J].Stroke,2021,52(9):3045-3053. [4] CHEN X M, HE Y N, MENG X M, et al.Factors associated with perceived participation three months after being discharged from a tertiary hospital[J].Clinical Rehabilitation,2017,31(9):1257-1266. [5] 张亚珍,李兆妍.多学科联合质量改进方案在急性缺血性脑卒中患者深静脉血栓中的防控效果[J].四川生理科学杂志,2023,45(2):204-207,329. [6] 李翠华,宁芳,李孟娟.基于预见性理论的精细化护理在预防脑卒中偏瘫患者下肢静脉血栓栓塞症中的应用效果[J].黑龙江中医药,2023,52(2):304-306. [7] DAL Y, NAZıROĞLU M, ÖZKAYA M O. Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia:Involvements of TRPM2 and TRPV1 channels[J].J Obstet Gynaecol Res,2023,49(5):1355-1365. [8] XIA Z N, ZHOU Q, ZHU W, et al.Low molecular weight heparin for the prevention of deep venous thrombosis after total knee arthroplasty:A systematic review and meta-analysis[J].Int J Surg,2018,54(Pt A):265-275. [9] 徐文芳,胡月,张静.循证护理在冠心病皮下注射低分子肝素致皮下出血中的应用研究[J].当代护士,2023,30(6):119-122. [10] 杜晓亮,余星,厉春林,等.神经外科术中获得性压力性损伤的预防护理专案[J].护理学杂志,2022,37(19):45-48. [11] 高艳丽,于玲玲,冯东亮,等.护理专案改善活动对阿片类药物治疗膝骨关节炎患者不良反应、负性情绪和镇痛效果的影响[J].中国药物滥用防治杂志,2024,30(4):626-629. [12] 陈春兰. 开展护理专案在预防脑出血术后卧床患者下肢静脉血栓发生的效果[J].基层医学论坛,2023,27(32):79-81. [13] 万学红,卢雪峰.诊断学[M].8版,北京:人民卫生出版社,2013:95-96,296-297. [14] DEHGHANI K, NAJARI Z, DEHGHANI H.Efect of subeutaneaasEnosapsrin injection duratiom on bruising size in acute comonarysyndrome pafients[J].Iran J Nurs Midwifery Res,2014,19(6):564-568. [15] 申萍,施毅.用面部表情量表法评估疼痛[J].国外医学.护理学分册,1998,3:29. [16] 张海波. 慢性疼痛病人疼痛相关因素的调查与心理干预研究[D].太原:山西医科大学,2014. [17] QIU M, HUANG S J, LUO C H, et al.Pharmacological and clinical application of heparin progress:an essential drug for modern medicine[J].Biomedecine Pharmacother,2021,139:111561. [18] STEVENS S M, WOLLER S C, BAUMANN KREUZIGER L, et al.Executive summary:antithrombotic therapy for VTE disease:second update of the CHEST guideline and expert panel report[J].Chest,2021,160(6):2247-2259. [19] 赵丹丹. 低分子肝素钙联合阿替普酶对急性缺血性脑卒中患者神经功能的影响[J].实用中西医结合临床,2021,21(11):54-55. [20] 于丽琴. 阿替普酶静脉溶栓及低分子肝素钙注射液联合曲克芦丁抗凝治疗急性缺血性脑卒中患者的临床研究[J].基层医学论坛,2022,26(28):78-80. [21] 单荣芳,陈黎敏,徐晓芳.皮下注射低分子肝素钙预防皮下出血的研究进展[J].当代护士(上旬刊),2022,29(1):33-35. [22] 段艳芹,陈娟,赵钰.循证护理实践规范抗凝剂皮下注射对脑卒中患者发生皮下出血的影响及其影响因素研究[J].实用心脑肺血管病杂志,2020,28(4):49-53. [23] 雷霞. 低分子肝素皮下注射方法及护理进展[J].当代护士(中旬刊),2019,26(3):16-18. [24] 赵琳,钟博华,王英,等.低分子肝素钙不同注射时间对COPD急性加重期病人皮下出血和疼痛的影响[J].护理研究,2017,31(32):4145-4146. [25] 芦青华,高云秀,王晶,等.低分子肝素钙皮下注射时间及拔针时机对患者疼痛及皮下出血的影响[J].齐鲁护理杂志,2015,21(23):94-96. |